BB Biotech AG | Income Statement
Fiscal year is January-December. All values CHF Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
184,756.00
221,245.00
291,996.00
11,583.00
270,324.00
Unusual Expense
600.00
-
-
-
-
Pretax Income
931,970.00
1,470,217.00
652,896.00
801,994.00
687,580.00
Consolidated Net Income
931,834.00
1,470,139.00
652,816.00
802,065.00
687,503.00
Net Income
931,834.00
1,470,139.00
652,816.00
802,065.00
687,503.00
Net Income After Extraordinaries
931,834.00
1,470,139.00
652,816.00
802,065.00
687,503.00
Net Income Available to Common
931,834.00
1,470,139.00
652,816.00
802,065.00
687,503.00
EPS (Basic)
16.35
25.96
11.69
14.51
12.42
Basic Shares Outstanding
56,982.00
56,632.70
55,849.70
55,265.00
55,345.80
EPS (Diluted)
16.35
25.95
11.68
14.51
12.42
Diluted Shares Outstanding
56,982.00
56,646.90
55,868.20
55,265.00
55,351.50
Total Expense
747,463.00
1,248,066.00
362,234.00
814,155.00
417,250.00
Operating Income
932,219.00
1,469,311.00
654,230.00
802,572.00
687,574.00
Income Taxes
136.00
78.00
80.00
71.00
77.00
Non-Operating Income (Expense)
351.00
906.00
1,334.00
578.00
6.00
About BB Biotech
View Profile
